Similarly, tumor upregulation of PD-L1 expression, commonly induced by infiltrating T-cell release of interferon-γ (IFN-γ) 27, leads to inactivation of T cells expressing PD-1, further enabling tumor cell evasion of immune destruction (Fig. 1). The gene discussed is PDCD1; the disease is neoplasm.